Karlijn L. Van Rooijen

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.

Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study.

Journal: The British journal of surgery

Published: June 26, 2025

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.

Upfront resection versus no resection of the primary tumor in patients with synchronous metastatic colorectal cancer: the randomized phase III CAIRO4 study conducted by the Dutch Colorectal Cancer Group and the Danish Colorectal Cancer Group.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 05, 2024

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review.

Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review.

Journal: Cancers

Published: March 25, 2022

Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer.

Translation of IDEA trial results into clinical practice: Analysis of the implementation of a new guideline for colon cancer.

Journal: International journal of cancer

Published: October 27, 2021

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.

Sixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial.

Journal: JAMA surgery

Published: October 06, 2021

Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients.

Role of Up-Front Primary Tumor Resection and Tumor Sidedness in the Survival of Synchronous Metastatic Colon Cancer Patients.

Journal: Digestive surgery

Published: October 20, 2020

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.

Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study.

Journal: BMC cancer

Published: July 22, 2020

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing.

Journal: Scientific reports

Published: October 29, 2019

Genome-wide cell-free DNA fragmentation in patients with cancer.

Genome-wide cell-free DNA fragmentation in patients with cancer.

Journal: Nature

Published: November 19, 2018

Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.

Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 05, 2017

A role for activated endothelial cells in red blood cell clearance: implications for vasopathology.

A role for activated endothelial cells in red blood cell clearance: implications for vasopathology.

Journal: Haematologica

Published: November 22, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026